DK262486A - Heterocyclisk substituerede 1,2,3,5-tetrahydro-imidazo (2,1-b) quinazolin-2(1h)-on-forbindelser, deres anvendelse til fremstilling af hjertestimulerende laegemidler, farmaceutiske praeparater samt forbindelser til anvendelse som udgangsmateriale ved deres fre - Google Patents

Heterocyclisk substituerede 1,2,3,5-tetrahydro-imidazo (2,1-b) quinazolin-2(1h)-on-forbindelser, deres anvendelse til fremstilling af hjertestimulerende laegemidler, farmaceutiske praeparater samt forbindelser til anvendelse som udgangsmateriale ved deres fre Download PDF

Info

Publication number
DK262486A
DK262486A DK262486A DK262486A DK262486A DK 262486 A DK262486 A DK 262486A DK 262486 A DK262486 A DK 262486A DK 262486 A DK262486 A DK 262486A DK 262486 A DK262486 A DK 262486A
Authority
DK
Denmark
Prior art keywords
preparations
pharmaceutical preparations
stimulative
quinazolin
imidazo
Prior art date
Application number
DK262486A
Other languages
Danish (da)
English (en)
Other versions
DK262486D0 (da
Inventor
Simon Fraser Campbell
David Anthony Roberts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858514207A external-priority patent/GB8514207D0/en
Priority claimed from GB858527208A external-priority patent/GB8527208D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of DK262486D0 publication Critical patent/DK262486D0/da
Publication of DK262486A publication Critical patent/DK262486A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK262486A 1985-06-05 1986-06-04 Heterocyclisk substituerede 1,2,3,5-tetrahydro-imidazo (2,1-b) quinazolin-2(1h)-on-forbindelser, deres anvendelse til fremstilling af hjertestimulerende laegemidler, farmaceutiske praeparater samt forbindelser til anvendelse som udgangsmateriale ved deres fre DK262486A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858514207A GB8514207D0 (en) 1985-06-05 1985-06-05 Cardiac stimulants
GB858527208A GB8527208D0 (en) 1985-11-05 1985-11-05 Cardiac stimulants

Publications (2)

Publication Number Publication Date
DK262486D0 DK262486D0 (da) 1986-06-04
DK262486A true DK262486A (da) 1987-02-16

Family

ID=26289332

Family Applications (1)

Application Number Title Priority Date Filing Date
DK262486A DK262486A (da) 1985-06-05 1986-06-04 Heterocyclisk substituerede 1,2,3,5-tetrahydro-imidazo (2,1-b) quinazolin-2(1h)-on-forbindelser, deres anvendelse til fremstilling af hjertestimulerende laegemidler, farmaceutiske praeparater samt forbindelser til anvendelse som udgangsmateriale ved deres fre

Country Status (16)

Country Link
US (1) US4783467A (xx)
EP (1) EP0205280A3 (xx)
KR (1) KR870001362B1 (xx)
CN (1) CN86103833A (xx)
AU (1) AU562773B2 (xx)
CA (1) CA1270486A (xx)
DK (1) DK262486A (xx)
ES (2) ES8708139A1 (xx)
FI (1) FI862375A (xx)
GR (1) GR861425B (xx)
HU (1) HU196408B (xx)
IL (1) IL79003A0 (xx)
NO (1) NO862233L (xx)
NZ (1) NZ216386A (xx)
PT (1) PT82702B (xx)
YU (1) YU95186A (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783467A (en) * 1985-06-05 1988-11-08 Pfizer Inc. Tetrahydroimidazoquinazolinone inotropic agents
CA2113115A1 (en) * 1991-07-29 1993-02-18 Vlad E. Gregor Quinazoline derivatives as acetylcholinesterase inhibitors
US7700608B2 (en) 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US8383637B2 (en) * 2004-08-06 2013-02-26 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8436006B2 (en) * 2004-08-06 2013-05-07 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8426429B2 (en) * 2004-08-06 2013-04-23 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US7910597B2 (en) 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
CN117062819A (zh) * 2021-03-23 2023-11-14 北京生命科学研究所 多环化合物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
US3983119A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
US3983120A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
NL7807507A (nl) * 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.
US4208521A (en) * 1978-07-31 1980-06-17 Bristol-Myers Company Process for the preparation of imidazo[2,1-b]quinazolinones
CA1131631A (en) * 1979-06-20 1982-09-14 Madhukar S. Chodnekar Quinazoline derivatives and pharmaceutical preparations
EP0054180A3 (de) * 1980-12-16 1982-12-01 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung eines Imidazochinazolinonderivates
JPS604186A (ja) * 1983-06-21 1985-01-10 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン化合物
JPS6028979A (ja) * 1983-07-14 1985-02-14 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン類化合物
US4593029A (en) * 1984-02-15 1986-06-03 Syntex (U.S.A.) Inc. Novel ω-(N-imidazolyl)alkyl ethers of 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
US4783467A (en) * 1985-06-05 1988-11-08 Pfizer Inc. Tetrahydroimidazoquinazolinone inotropic agents

Also Published As

Publication number Publication date
EP0205280A3 (en) 1988-11-30
FI862375A (fi) 1986-12-06
AU562773B2 (en) 1987-06-18
ES555723A0 (es) 1987-09-16
FI862375A0 (fi) 1986-06-04
KR870000338A (ko) 1987-02-17
PT82702B (pt) 1988-12-15
NZ216386A (en) 1988-08-30
US4783467A (en) 1988-11-08
YU95186A (en) 1988-04-30
CN86103833A (zh) 1986-12-31
HUT41793A (en) 1987-05-28
ES8800224A1 (es) 1987-10-16
IL79003A0 (en) 1986-09-30
HU196408B (en) 1988-11-28
ES557427A0 (es) 1987-10-16
EP0205280A2 (en) 1986-12-17
ES8708139A1 (es) 1987-09-16
GR861425B (en) 1986-10-02
KR870001362B1 (ko) 1987-07-20
NO862233D0 (no) 1986-06-04
NO862233L (no) 1986-12-08
DK262486D0 (da) 1986-06-04
AU5842786A (en) 1986-12-11
PT82702A (en) 1986-07-01
CA1270486A (en) 1990-06-19

Similar Documents

Publication Publication Date Title
DK236085A (da) Heterocyclisk substituerede 2(ah)-quinolon-forbindelser og forbindelser til anvendelse som mellemprodukter ved deres fremstilling samt farmaceutiske praeparater
DK335686D0 (da) Fremgangsmaade til fremstilling af 1-carba-3-cephem-4-carboxylsyrer ogderivater deraf samt mellemprodukter til brug ved fremgangsmaaden
DK170287A (da) Fremgangsmaade til fremstilling af findelte, pulverformede karotinoidpraeparater
NO170884C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
DK534286D0 (da) Nicotinsyrederivater, deres fremstilling og anvendelse som herbicider samt mellemprodukter ved fremstillingen og disses fremstilling
DK86193A (da) Fremgangsmaade til fremstilling af trifluorbenzoesyrederivater
NO863574D0 (no) Fremgangsmaate ved fremstilling av tetrafluorbenzosyre.
DK570486A (da) Heterocyclisk substituerede 2(1h)-quinoloner, deres anvendelse til fremstilling af hjertestimulerende laegemidler, farmaceutiske praeparater indeholdende forbindelserne og mellemprodukter ved deres fremstilling
DK262486D0 (da) Heterocyclisk substituerede 1,2,3,5-tetrahydro-imidazo (2,1-b) quinazolin-2(1h)-on-forbindelser, deres anvendelse til fremstilling af hjertestimulerende laegemidler, farmaceutiske praeparater samt forbindelser til anvendelse som udgangsmateriale ved deres fre
DK641187A (da) Fremgangsmaade til fremstilling af vandfri alkansulfonsyre
DK419887D0 (da) Triazolopyrimidin-2-sulfonamider, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse som herbicider
DK458688D0 (da) Benzensulfonylcarboxamidforbindelser, fremgangsmaader og mellemprodukter til deres fremstilling samt anvendelse af forbindelserne og mellemprodukterne som herbicider
DK537687A (da) Fremgangsmaade til fremstilling af n-substituerede piperazinoner
NO169962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
DK437287D0 (da) 2,3-dihydrofuranderivater, deres fremstilling og deres anvendelse som mellemprodukter til fremstilling af tetrahydrofuranderivater
DK11089D0 (da) 2,5-diazabicyclooe2.2.1aaheptan-forbindelser, deres anvendelse til fremstilling af antiarytmi-laegemidler, farmaceutiske praeparater indeholdende forbindelserne samt forbindelse til anvendelse som udgangsmateriale ved deres fremstilling
NO864525D0 (no) Fremgangsmaate ved fremstilling av aryleddiksyrederivater.
DK562686A (da) 2,2 -bi-1h-imidazoler, tautomere og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse som cardiotonika samt mellemprodukter ved fremstillingen
DK181387A (da) Fremgangsmaade til fremstilling af n-(sulfonylmethyl)formamider
DK165689C (da) 1,5-disubstituerede imidazolderivater, fremgangsmaade til fremstilling af saadanne forbindelser, fungicidt praeparat indeholdende saadanne forbindelser samt anvendelse af saadanne forbindelser som fungicider
DK204891D0 (da) Hidtil ukendte cyanoalkylbenzamidderivater, fremgangsmaade til fremstilling deraf, samt anvendelse af saadanne cyanoalkylbenzamidderivater som mellemprodukt ved fremstilling af substituerede n-(imidazolinyl-methyl)-benzamider
DK657787A (da) 1-benzylsulfonyl-3-heteroaryl-(thio)urinstoffer, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse som herbicider
DK649787A (da) Fremgangsmaade til fremstilling af optisk aktive smoersyrederivater
DK32487A (da) 2,4-diamino-6-halogenalkylpyrimidiner, fremgangsmaade til deres fremstilling og deres anvendelse som herbicider
DK131687D0 (da) N-substituerede aminoalkansyrer, fremgangsmaader til deres fremstilling, deres anvendelse samt farmaceutiske praeparater paa grundlag af disse forbindelser

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment